This advanced MVA manufacturing process is expected to significantly simplify vaccine production, particularly in middle- and low-income regions where supply chain issues often hinder access to ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

Innovative approaches to streamlining biologics production with integrated continuous technologies. Continuous manufacturing ...

which is now in the process of catching up.-Timothy Mercer, University of Queensland For Mercer, bringing sequencing methods into that ecosystem was an intuitive solution for improving quality control ...

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process ... of our vaccine and therapeutic protein production ...

Moderna first announced it would scale down manufacturing of its Spikevax COVID-19 vaccine in late 2023, including at contract drug manufacturer Lonza's (LONN.S), opens new tab facility in ...

This site is earmarked for the construction of an end-to-end vaccine manufacturing facility, showcasing Kenya's commitment to healthcare advancement. In 2022, Kenya initiated the process of ...

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide 27.01.2025 / 15:04 CET/CEST The issuer is solely responsible for the content of this announcement. Process ...